Cibus, Inc. (CBUS)
NASDAQ: CBUS · Real-Time Price · USD
1.320
-0.010 (-0.75%)
At close: Nov 26, 2025, 4:00 PM EST
1.340
+0.020 (1.52%)
After-hours: Nov 26, 2025, 7:15 PM EST
Cibus Market Cap
Cibus has a market cap or net worth of $71.65 million as of November 26, 2025. Its market cap has decreased by -54.07% in one year.
Market Cap
71.65M
Enterprise Value
307.23M
1-Year Change
-54.07%
Ranking
Category
Stock Price
$1.32
Market Cap Chart
Since July 20, 2017, Cibus's market cap has decreased from $288.70M to $71.65M, a decrease of -75.18%. That is a compound annual growth rate of -15.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 25, 2025 | 72.20M | -12.17% |
| Dec 31, 2024 | 82.20M | -80.39% |
| Dec 29, 2023 | 419.20M | 5,722.22% |
| Dec 30, 2022 | 7.20M | -91.22% |
| Dec 31, 2021 | 82.00M | -47.57% |
| Dec 31, 2020 | 156.40M | -32.29% |
| Dec 31, 2019 | 231.00M | -31.54% |
| Dec 31, 2018 | 337.40M | -44.70% |
| Dec 29, 2017 | 610.10M | 111.33% |
| Jul 20, 2017 | 288.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 290.32B |
| Merck & Co. | 259.69B |
| Novartis AG | 251.09B |
| Abbott Laboratories | 223.51B |